Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT00744081 · COMPLETED
Trial details
- NCT number
- NCT00744081
- Sponsor
- Goethe University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.